Tourette Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

First Patient Dosed in Phase 3 Trial of Ecopipam for Tourette Syndrome
CHICAGO, March 1, 2023. Emalex Biosciences announced that the first patient was dosed in its Phase 3 clinical trial evaluating ecopipam for the treatment of Tourette Syndrome. Participants in the trial receive ecopipam for 12 weeks in the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 1, 2023 Category: Pharmaceuticals Source Type: clinical trials

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
Condition: Tourette Syndrome Intervention: Device: transcranial magnetic stimulation Sponsors: West Virginia University; University of Florida; Tourette Association of America Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials

Tourette Discrimination (TD) Stigma Scale
Conditions: Tourette Syndrome; Tourette Syndrome in Children; Tourette Syndrome in Adolescence; Tic Disorder, Childhood; Tics Intervention: Sponsors: Wake Forest University Health Sciences; Tourette Association of America; University of Rochester Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2023 Category: Research Source Type: clinical trials